David Durantel
Impact in
- Hepatology top 0.2%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Epidemiology top 0.2%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
Papers in
- Epidemiology 96
- Hepatitis B Virus Studies 86
- Liver Disease Diagnosis and Treatment 24
- Hepatology 73
- Hepatitis C virus research 70
- Hepatitis Viruses Studies and Epidemiology 12
- Co-authors
- Fabien Zoulim (68 shared papers)Charles Dumontet (1 shared paper)Lars Petter Jordheim (1 shared paper)Julie Lucifora (36 shared papers)O. Hantz (8 shared papers)Sandra Carrouée‐Durantel (8 shared papers)Nicole Zitzmann (13 shared papers)Raymond A. Dwek (9 shared papers)
- Journals
- Journal of Hepatology (19 papers)Antiviral Research (15 papers)Hepatology (12 papers)Journal of Virology (6 papers)Antimicrobial Agents and Chemotherapy (5 papers)
- Partner nations
- FranceUnited StatesGermany
In The Last Decade
David Durantel
128 papers receiving 6.4k citations
David Durantel's Hit Papers
Peers
Comparison fields: 5 of 135
- Hepatology 2.6k
- Epidemiology 3.7k
- Infectious Diseases 1.3k
- Virology 302
- Immunology 745
Countries citing papers authored by David Durantel
This map shows the geographic impact of David Durantel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Durantel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Durantel more than expected).
Fields of papers citing papers by David Durantel
This network shows the impact of papers produced by David Durantel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Durantel. The network helps show where David Durantel may publish in the future.
Co-authors
The 25 scholars most cited alongside David Durantel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 134 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases Hit paper breakdown → | 2013 | 982 |
| 2 | 2011 | 372 | |
| 3 | 2020 | 288 | |
| 4 | 2003 | 243 | |
| 5 | 2005 | 215 | |
| 6 | 2016 | 156 | |
| 7 | 2001 | 142 | |
| 8 | 2016 | 123 | |
| 9 | 2008 | 120 | |
| 10 | 2010 | 119 | |
| 11 | 2016 | 118 | |
| 12 | 2015 | 118 | |
| 13 | 2009 | 114 | |
| 14 | 2015 | 111 | |
| 15 | 2009 | 107 | |
| 16 | 2009 | 106 | |
| 17 | 2009 | 91 | |
| 18 | 2017 | 87 | |
| 19 | Celgosivir, an alpha-glucosidase I inhibitor for the potential treatment of HCV infection. | 2009 | 85 |
| 20 | 2018 | 82 |
About David Durantel
David Durantel is a scholar working on Epidemiology, Hepatology, Infectious Diseases, Immunology and Molecular Biology, having authored 134 papers that have together received 6.5k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (86 papers), Hepatitis C virus research (70 papers), Liver Disease Diagnosis and Treatment (24 papers), Hepatitis Viruses Studies and Epidemiology (12 papers), interferon and immune responses (8 papers), Immunotherapy and Immune Responses (8 papers), HIV/AIDS drug development and treatment (8 papers) and Viral gastroenteritis research and epidemiology (6 papers). The work is most often cited by research in Hepatology (2.6k citations), Epidemiology (3.7k citations), Infectious Diseases (1.3k citations), Virology (302 citations) and Immunology (745 citations). David Durantel has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Fabien Zoulim, Charles Dumontet, Lars Petter Jordheim, Julie Lucifora, O. Hantz, Sandra Carrouée‐Durantel, Nicole Zitzmann, Raymond A. Dwek, Massimo Levrero and Barbara Testoni. Their work appears in journals such as Journal of Hepatology, Antiviral Research, Hepatology, Journal of Virology and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.